Drug-drug interactions in patients from an internal medicine service;Interacciones medicamentosas en pacientes de un servicio de medicina interna

Farmacia Hospitalaria

Volumn 32, Issue 5, 2008, Pages 293-297

  Ibanez A ^a   Alcala M ^a   Garcia J ^a   Puche, E ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

Drug interactions; Hospital; Internal Medicine; Patients

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CARBAMAZEPINE; CARVEDILOL; CLORAZEPATE; DIAZEPAM; DICLOFENAC; DIGOXIN; DILTIAZEM; DIURETIC AGENT; FUROSEMIDE; IBUPROFEN; INDOMETACIN; INSULIN; METHADONE; METILDIGOXIN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PHENYTOIN; PREDNISONE; RIFAMPICIN;

ADULT; AGED; ARTICLE; BLEEDING; BRADYCARDIA; CLINICAL PROTOCOL; COMORBIDITY; DIGITALIS INTOXICATION; DRUG INTERACTION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; SEDATION; SIDE EFFECT;

EID: 59749101725     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1130-6343(08)75950-6     Document Type: Editorial

References (17)

1. Crespo C.A., Guerrero E., Sanmartín P., Castro B., and Vila J.L. Interacciones entre medicamentos: Detección precoz mediante un sistema computarizado. Farm Hosp 16 Supl 1 (1992) 38-44
2. Comet D., Casajuana J., Bodas J.M., Fuentes M.A., Arnaiz J.A., Núñez B., et al. Interacciones farmacológicas en la prescripción crónica. Aten Prim 20 (1997) 71-74
3. Bjerrum L., Andersen M., Petersen G., and Kragstrup J. Exposure to potential drug interactions in primary health care. Scand J Prim Health Care 21 (2003) 153-158
4. Vargas E., Navarro M.I., Laredo L., García-Arenillas M., García-Mateos M., and Moreno A. Effect of drug interactions on the development of adverse drug reactions. Clin Drug Invest 13 (1997) 282-289
5. López P., Rodríguez C., Durán C., Tato F., Rodríguez I., and Lado F.L. Interacciones entre medicamentos prescritos al alta en un servicio de medicina interna. An Med Interna (Madrid) 22 (2005) 69-75
6. Peral J., Lertxundi U., Martínez M.J., Mora O., Franco E., and Gabilondo I. Evaluación prospectiva de interacciones entre medicamentos en pacientes ingresados mediante aplicación informática. Farm Hosp 31 (2007) 93-100
7. Guédon-Moreau L., Ducrocq D., Duc M.F., Quieureux Y., Hote L., Deligne J., et al. Absolute contraindications in relation to potential drug intractions in outpatient prescriptions : analysis of the first five million prescriptions in 1999. Eur J Clin Pharmacol 59 (2003) 689-695
8. Jankel C., and Fitterman L. Epidemiology of drug-drug interactions as a cause of hospital admissions. Drug Safety 9 (1993) 51-59
9. Seymur R., and Routledge P. Important drug-drug interactions in the elderly. Drugs Aging 12 (1998) 485-494
10. Juurlink D., Mamdani M., Kopp A., Laupacis A., and Redelmeier D. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 289 (2003) 1652-1658
11. Hansten P, Horn J. Drug interactions analysis and management. St. Louis, Missouri: Ed. Wolters Kluwer Health; 2006.
12. Charlson M., Szatrowski T., Peterson J., and Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 47 (1994) 1245-1251
13. Glintborg B., Andersen S., and Dalhoff K. Drug-drug interactions among recently hospitalised patients-frequent but mostly clinically insignificant. Eur J Clin Pharmacol 61 (2005) 675-681
14. Cruciol J.H., and Thomson J.C. Prevalence of potencial drug-drug interactions and its associated factors in a brazilian teaching hospital. J Pharm Pharmaceut Sci 9 (2006) 427-433
15. Vonbach P., Dubied A., Beer J., and Krähenbühl S. Recognition and management of potential drug-drug interactions in patients on internal medicine wards. Eur J Clin Pharmacol 63 (2007) 1075-1083
16. Morales-Olivas F., and Estañ L. Interacciones medicamentosas. Nuevos aspectos. Med Clin (Barc) 127 (2006) 269-275
17. Hazell L., and Shakir S. Under reporting of adverse drug reactions: a systematic review. Drug Saf 29 (2006) 385-396